Great to be a part of the 58th Annual Japanese Society of Nuclear Medicine #2018JSNM.
The conference theme is “theranostics” and it is clear that therapeutic nuclear medicine is gaining momentum in Japan. 🇯🇵
Home
Latest News
Telix Receives Approval to Commence Glioblastoma Trial
Melbourne (Australia), Brussels (Belgium) – 18th of October 2018. Telix Pharmaceuticals Limited has today announced...Read More
October 19, 2018
Telix Selects RTM to Manufacture Kidney Imaging Program in Europe
Melbourne (Australia) and Nijmegen (the Netherlands) – 17 October 2018. Telix Pharmaceuticals Limited announced that...Read More
October 19, 2018
Load More...